In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
484 News Items found
Dr. Michael Overholtzer
Feature
17 Gerstner Sloan Kettering Students Will Graduate in 2023

Seventeen scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 17, 2023, as part of Memorial Sloan Kettering’s 44th annual academic convocation.
Detail shot of an MSK scientist in the lab
MSK Research Highlights, January 29, 2024

New MSK research provides insights into how BRCA2 promotes genomic integrity; illuminates how embryonic cells can develop without key amino acids; explores how the microbiome bounces back after antibiotic treatment; and investigates acquired resistance to immunotherapy in non-small cell lung cancer.
Ivan Maillard
At Work
A ‘Matchmaker’ Between the Lab and the Clinic: At Work With Ivan Maillard

A passion for both science and the humanities has informed the life and career of Dr. Ivan Maillard, who was recently selected to lead the Division of Hematologic Malignancies at MSK.
MSK Experts Weigh in on Mammography Debate

Many women are confused by conflicting guidelines on breast screening. And the latest recommendations made by the USPSTF are adding to that confusion. MSK experts are available to answer questions and explain what MSK recommends and why it is not altering its guidelines. To schedule an interview with a member of MSK’s breast cancer leadership team, please contact Nicole McNamara at [email protected].
MRI of brain and spinal fluid in green
In the Clinic
Analyzing Spinal Fluid Could Guide Brain Tumor Diagnosis and Treatment

Cancer DNA taken from spinal fluid could serve as a liquid biopsy that provides information on brain tumor mutations.
MSK Postdoc Luis Felipe Somarribas Patterson in the lab
MSK Postdoc Spotlight: Luis Felipe Somarribas Patterson

Luis Felipe Somarribas Patterson joined the Santosha Vardhana Lab as a postdoc in 2021. He investigates how metabolism influences different cell types, including immune cells, and conducts research into “exhausted T cells,” a state of T cell dysfunction that arises during chronic infections and cancer.
To our Community
A Message From Dr. Selwyn Vickers, MSK’s President and CEO

Learn about immunotherapy advances for cancer treatment from Dr. Selwyn Vickers, President and CEO of Memorial Sloan Kettering.
Microscopy image showing a quiescent cluster of lung adenocarcinoma tumor cells with low STING expression.
MSK Scientists Identify Potential New Strategy Against Metastasis

A team of scientists at the Sloan Kettering Institute has identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after they’ve escaped from a primary tumor.
Nadeem Riaz (left) and Jorge Reis-Filho (right)
For People with Certain BRCA Mutations, Activating the Immune System Could Be Promising Treatment

Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.
Karen Granville
Karen Granville Believes in Paying it Forward for Women’s History Month

Karen Granville works as a patient advocate to increase their access to MSK for cancer treatment.